Acorda Therapeutics Clinical Trials
Sponsors / Acorda Therapeutics
Acorda Therapeutics is listed as the lead sponsor on 56 clinical trials registered with ClinicalTrials.gov. 0 trials are actively recruiting participants, 0 remain active without open enrollment, and 47 have concluded. 9 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include safety concerns, slow or insufficient recruitment. The cumulative planned enrollment figure across all listed trials is 5,817 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
56
Total Trials
0
Recruiting
0
Other Active
47
Completed
9
Terminated / Withdrawn
5,817
Total Enrollment
Termination reasons: Other56% · Safety33% · Recruitment11%
Recent Terminations
- Idiopathic Parkinson Disease"New Safety Information"
- Hepatic Impairment"New Safety Information"
- Abuse Potential"New Safety Information"
- Post-ischemic Stroke
- Epilepsy
- Refractory Epilepsy
- Acute Spinal Cord Injury"The study was terminated by the Sponsor due to insufficient enrollment."
- Spasticity Due to Cerebral Palsy"Please see 'Further study details as provided by Acorda Therapeutics' for explanation of why study stopped."
- NCT01446575 Phase PHASE4Transverse Myelitis"This study was redesigned to be more statistically rigorous."